Accidental and Surreptitious Intake of Oral Anticoagulants Including Older and Newer Agents - A Diagnostic Dilemma
Journal Title: Journal of Hematology & Thrombosis - Year 2017, Vol 3, Issue 1
Abstract
The newer oral anticoagulants including dabigatran, rivaraxoban, apixaban and edoxaban are replacing warfarin in the management of atrial fibrillation and venous thromboembolism. Accidental and surreptitious overdose of warfarin has been reported, but so far there is no reported case of overdose involving NOACs. Overdose of warfarin prolongs coagulation tests including PT and APTT. This gives a clue as to the underlying cause of bleeding, but with the newer oral anticoagulants these tests are of no value. The diagnosis and management of bleeding with accidental and surreptitious intake of oral anticoagulants is very difficult and high index of suspicion is needed.
Authors and Affiliations
Nathan Visweshwar
Keywords
Related Articles
- EP ID EP246552
- DOI 10.13188/2380-6842.1000018
- Views 116
- Downloads 0
Evaluation of Schistocytosis in Patients Treated with Dialysis
Schistocytes are associated with micro angiopathic hemolytic processes. In this retrospective study; we evaluate the association ofschistocytosis in the peripheral blood smear of patients before and after dialysis. We id...
Could Denosumab Support Bone Integrity in Sickle Cell Disease
Sickle cell anaemia is a congenital disease characterized by painful vaso-occlusive crises. It is associated with vitamin D deficiency, osteoporosis and recurrent attacks of micro-infarctions lead to bone osteonecrosis....
Recombinant Human Soluble Thrombomodulin is Effective for Severe Childhood EBV-HLH
Hemophagocytic lymphohistiocytosis (HLH) is a fatal disease, presenting with T cell-induced dysregulated cytokine production, systemic inflammation, and frequently intractable coagulopathy. We have administered recombina...
Accidental and Surreptitious Intake of Oral Anticoagulants Including Older and Newer Agents - A Diagnostic Dilemma
The newer oral anticoagulants including dabigatran, rivaraxoban, apixaban and edoxaban are replacing warfarin in the management of atrial fibrillation and venous thromboembolism. Accidental and surreptitious overdose of...
The Evaluation of Cardiac Disorders and Systemic Hypertension in JAK2V617F Positive Patients at a Multicenter Institution
In this retrospective study; we evaluate cardiac disorders and systemic hypertension in JAK2 V617F positive patients. We identified 1000 patients in our hospital system that had been evaluated for JAK2 V617F mutation. Am...